2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
US-12171741-B2 · Dec 24, 2024 · US
US8969592B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8969592-B2 |
| Application number | US-201213347305-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 10, 2012 |
| Priority date | Jan 10, 2012 |
| Publication date | Mar 3, 2015 |
| Grant date | Mar 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Novel heterocyclic materials are disclosed. The materials contain a fused tetracyclic structure that can improve the properties of OLED devices when the novel heterocyclic materials are incorporated into such devices.
Opening claim text (preview).
The invention claimed is: 1. A compound having the formula: wherein Q 1 to Q 8 are independently selected from CH and N, and wherein Q 1 to Q 8 may be further substituted; wherein X and Y are independently selected from the group consisting of O, S, and Se; wherein R 8 represents mono, di, tri, or tetra substitution; wherein R 9 represents mo…
Electricity · mapped topic
Electricity · mapped topic
Electricity · mapped topic
Electricity · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.